Company / Operating Cash Flow
Cyclerion Therapeutics, Inc. Operating Cash Flow History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$3.3M
FY2025
5-year range
-$72.5M / -$3.3M
FY2021-FY2025
Trend
+84.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$41M to -$3M over the past 2 years.
Based on SEC 10-K filings.
-$3M in FY2025.
Improved from -$41M to -$3M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow increased 84.4% year-over-year.
- Lowest operating cash flow in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -19.82 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$3.3M | +84.4% |
| FY2024 | -$21.2M | +47.7% |
| FY2023 | -$40.6M | +0.0% |
| FY2022 | -$40.6M | +44.0% |
| FY2021 | -$72.5M | +29.1% |
| FY2020 | -$102.2M | -4.8% |
| FY2019 | -$97.5M | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026